Jove
Visualize
Contact Us

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

194
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
194
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Impact Of Preoperative Inflammatory And Nutritional Markers On The Prognosis Of Patients With Peritoneal Metastasis Of Colorectal Cancer.

Impact of preoperative inflammatory and nutritional markers on the prognosis of patients with peritoneal metastasis of colorectal cancer.

Zhi-Jie Wu1,2,3, Bing Lan1,2,3, Jian Luo1,2,3

  • 1Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, Guangdong Province, China.

World Journal of Gastrointestinal Oncology
|October 1, 2024

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

29.9K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

View abstract on PubMed

Summary
This summary is machine-generated.

High neutrophil-to-lymphocyte ratio (NLR) and low hemoglobin (Hb) predict poor prognosis in colorectal cancer with peritoneal metastasis (CRC-PM). A developed nomogram accurately predicts overall survival (OS) for CRC-PM patients.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Cancer Prognostics

Background:

  • Identifying patients with colorectal cancer peritoneal metastasis (CRC-PM) who benefit from surgery is critical.
  • Inflammatory and nutritional markers are key in cancer development and metastasis.

Purpose of the Study:

  • To investigate the prognostic association of preoperative inflammatory and nutritional markers in patients with CRC-PM.

Main Methods:

  • Evaluated 133 CRC-PM patients (July 2012-July 2018).
  • Assessed demographics, overall survival (OS), and preoperative inflammatory/nutritional markers.
  • Utilized Kaplan-Meier method and log-rank test for survival analysis.

Main Results:

  • High neutrophil-to-lymphocyte ratio (NLR) correlated with significantly lower median OS (7.9 months vs. 25.4 months).
Keywords:
Colorectal cancerHemoglobinNeutrophil-to-lymphocyte ratioOverall survival

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

29.9K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
  • Low hemoglobin (Hb) was associated with shorter median OS (6.3 months vs. 18.5 months).
  • A nomogram incorporating age, carbohydrate antigen 199, NLR, Hb, and peritoneal cancer index showed good predictive capacity (C-index: 0.715).
  • Conclusions:

    • High NLR and low Hb are independent predictors of poor prognosis in CRC-PM.
    • The developed nomogram accurately predicts OS in CRC-PM patients.
    • The nomogram serves as a valuable prognostic tool for this patient group.
    Peritoneal metastasis
    Prognosis